Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. - Wikidata - awgldk - TriplyDB

Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.

Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.

http://www.wikidata.org/entity/Q40036183

about

Identification of sequences common to more than one therapeutic target to treat complex diseases: simulating the high variance in sequence interactivity evolved to modulate robust phenotypes Epigenetics in heart failure phenotypes Novel epigenetic-based therapies useful in cardiovascular medicine Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?Regulatory non-coding RNAs in acute myocardial infarction Novel methodologies for biomarker discovery in atherosclerosis The role of RNA interference in the developmental separation of blood and lymphatic vasculature Vascular endothelial growth factor signaling in hypoxia and inflammation.Phenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development.Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction Development of microRNA therapeutics is coming of age.Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7.Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes.Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury.Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine.Chronic Losartan Treatment Up-Regulates AT1R and Increases the Heart Vulnerability to Acute Onset of Ischemia and Reperfusion Injury in Male Rats.Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.MicroRNA Regulation of Atherosclerosis.Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4.Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1.Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats.Regulatory RNAs and paracrine networks in the heart.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.The ins and outs of microRNAs as biomarkers in liver disease and transplantation.Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review.Noncoding RNAs and myocardial fibrosis.Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.Unlocking the door to new therapies in cardiovascular disease: microRNAs hold the key.MiRNAs as potential molecular targets in heart failure.MicroRNAs in myocardial infarction.Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.Advanced Strategies for End-Stage Heart Failure: Combining Regenerative Approaches with LVAD, a New Horizon?MicroRNAs in cardiovascular ageing.Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

P2860

Q21146715-C43F5C53-744B-46E9-AA03-92ED16DA10A9 Q26747565-0710F59A-9E64-48BA-A9ED-C32D857F645A Q26765152-1E64CA28-28AA-4BFB-B63A-8591B6DBA1E5 Q26865593-89E60E1C-3E67-44B3-B68B-699E7F7FABEA Q27024879-07A37BE3-6AD6-4785-B391-41E4E2258B4F Q28076541-7F6CE404-8156-472C-910F-B203BCA40E6E Q28077279-A031921C-B574-43C5-AFAF-CB50044B8C14 Q28088373-A6481756-688C-4198-8843-8654FB09636A Q33615449-F241DFC4-9B25-4A62-8A0A-2382A2110C3E Q33721685-477EEF4B-D2F4-4EB9-A5F8-AD5CF1886F29 Q33825778-BC8AD7FA-C589-438A-ADA6-C4A32FF4A25F Q33853277-E90FE6A1-0E44-400B-8CEA-CB1E80F30C2C Q33991443-1D216B75-5CBF-41E7-88AB-DBF43536BB2C Q34478873-9DFA3DD6-FAA7-4462-8F9D-417D7AD25E54 Q35108624-CC4FA140-5FA9-42B8-9D43-625514FE4313 Q35114995-C5930A3A-4129-480E-9B4B-1C1C9BBFDD54 Q35152219-E6B49A4C-4573-4931-AB25-66AF4A71C0DB Q35190448-D5530D86-4788-4222-A5D5-6983DFA88100 Q35196236-CAC8A0CB-A79E-421B-BA75-4C915AE57FD9 Q35206513-01CEAFFD-46D2-4178-A5E5-E25BE0FCC6A2 Q35319305-B5663902-7603-4A96-B49B-D9DDEA7711D7 Q35689575-DE156D4A-9311-4284-A37D-2009B3367337 Q35866988-9795B824-90BF-4797-B450-415D8B5DA799 Q36602813-B9DF0D42-67B5-45D5-9461-FD89C3BEC6C1 Q37118803-C3E4733D-C0C9-4F9A-8861-2BA4980A00E6 Q37457656-F452AAAD-8F63-4DCF-BAAD-90F31F5A6537 Q37746255-2DB62F90-D2F4-42D6-B86E-5E409F02B78E Q38190443-871FB523-386D-41B4-B5EA-8E016955D1D1 Q38217461-70091654-9BE6-4929-A412-EFC7C1B4CAB0 Q38223103-9DAE4C91-43EC-4E67-9ACD-9A9110B5B29F Q38227381-D8EB0A59-5815-472E-8BF7-64973D38C06A Q38247018-084D2983-790E-4170-AF7C-05012FD57C05 Q38254809-6071534B-8C7F-485A-B19A-2CC13E0E95A3 Q38258936-9DEC502A-36C9-4A37-BF47-06D57E481BBE Q38286294-4092D4C2-FE00-4582-B29B-57755FB51DEB Q38289373-EFA91361-95F9-471D-B91D-D812AC63FD9C Q38290254-5B014450-C08A-4D57-9623-080B691112B0 Q38437316-00E41F32-5512-4284-9D25-F9788EB6C18E Q38514769-E2175A2B-92B2-4D36-86AB-64747082DAC3 Q38555602-55D96218-AD68-4FF7-AA57-F0317CE660D6

P2860

Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.

http://www.wikidata.org/entity/Q40036183

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Inhibition of microRNA-92a pro ...... njury in a large-animal model.

@en

type

label

Inhibition of microRNA-92a pro ...... njury in a large-animal model.

@en

prefLabel

Inhibition of microRNA-92a pro ...... njury in a large-animal model.

@en

P1433

Q40036183-368D6B92-D1B9-4AEE-82EF-03BF367BDC45

P1476

Q40036183-60C20D39-650D-488D-B801-5431A885506C

P2093

Q40036183-25047494-59CC-4F0A-B599-D02CD0448D07

Q40036183-3D0D42D0-0613-42BB-BB6C-89FA02D31F3A

Q40036183-4A7B0FCE-38CE-41EA-8861-D7123246D6D3

Q40036183-72E40FA3-8966-4026-8BEF-BCBEB7777C3C

Q40036183-B8F2DBB8-BAAD-4072-9869-8683E2A01745

Q40036183-D80CC2C9-5280-4A5C-825C-F3B589E5149C

Q40036183-E2F38341-263E-4088-84A4-EBBC48E79F6E

Q40036183-E4DAB9A3-F1B8-498F-92C0-A8806EB12609

P304

Q40036183-F31DFB03-98EF-4CA0-BF6A-7D0252E68A0F

P31

Q40036183-3CF9237A-B964-4289-B560-4A56E66E473F

P356

Q40036183-48867ED3-763C-4A98-B688-10D87BF2244C

P407

Q40036183-567B4210-34D1-4CE9-B888-F4F56B3BD731

P433

Q40036183-341C0A55-3F74-4630-94BE-E2DA69140806

P478

Q40036183-31CECF5D-7FDB-4A05-ACC9-F4C631FDDBF1

P50

Q40036183-360A49CE-B324-4A64-BEAC-841354BA45EC

Q40036183-ADCBBB54-1D53-4948-A0F1-288E36C409D5

Q40036183-DC8A11C5-499A-4EE3-BCDE-CAAE5BC2BBC8

P577

Q40036183-61456E92-12C7-4AE3-AE4F-CC11F2AED6B2

P698

Q40036183-34772000-299B-4822-B0BC-67CEA39A21B9

P921

Q40036183-127449A0-F816-491E-875C-71324867AD5F

Q40036183-291048CC-9E42-45D2-9855-AE92C2E7215F

Q40036183-6555C11B-22F4-4A23-B9D1-54154C3DE92E

Q40036183-9D8B9D36-89AB-4376-A6ED-69597F4DD136

Q40036183-ED858722-A193-4B58-8146-88985E103DA7

Q40036183-EDC51A6A-23D8-4BBA-A3EC-234CEA26E3C7

P356

CIRCULATIONAHA.113.001904

P1433

P1476

Inhibition of microRNA-92a pro ...... njury in a large-animal model.

@en

P2093

Ariane Fischer

http://www.w3.org/2001/XMLSchema#string

Christian Kupatt

http://www.w3.org/2001/XMLSchema#string

Daniela Penzkofer

http://www.w3.org/2001/XMLSchema#string

Elisabeth Baloch

http://www.w3.org/2001/XMLSchema#string

Eva van Rooij

http://www.w3.org/2001/XMLSchema#string

Quan-Fu Xu

http://www.w3.org/2001/XMLSchema#string

Stefanie Zühlke

http://www.w3.org/2001/XMLSchema#string

Wira Husada

http://www.w3.org/2001/XMLSchema#string

P304

1066-1075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.113.001904

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie Dimmeler

P577

2013-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23897866

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

leukocyte adhesion to vascular endothelial cell

negative regulation of leukocyte adhesion to vascular endothelial cell

positive regulation of leukocyte adhesion to vascular endothelial cell

regulation of leukocyte adhesion to vascular endothelial cell